FLT3 and non-small cell lung carcinoma: Also, immunofluorescence of LAMP1 similarly a diffused cellular distribution of lysosomes in cell lines from leukemia (MV‐4‐11), bladder (J82), and NSCLC (H1781) cancers with FLT3, FGFR, and Her2 tyrosine kinase mutations, respectively (Figure 4G, middle and right panels).